Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

VirnetX Holding (VHC) Research & Development (2016 - 2025)

VirnetX Holding's Research & Development history spans 10 years, with the latest figure at $1.1 million for Q3 2025.

  • For Q3 2025, Research & Development fell 2.81% year-over-year to $1.1 million; the TTM value through Sep 2025 reached $6.0 million, down 0.84%, while the annual FY2024 figure was $6.0 million, 37.84% down from the prior year.
  • Research & Development for Q3 2025 was $1.1 million at VirnetX Holding, down from $1.2 million in the prior quarter.
  • Across five years, Research & Development topped out at $4.8 million in Q2 2023 and bottomed at $1.1 million in Q3 2025.
  • The 5-year median for Research & Development is $1.2 million (2022), against an average of $1.7 million.
  • The largest annual shift saw Research & Development surged 278.88% in 2023 before it tumbled 74.28% in 2024.
  • A 5-year view of Research & Development shows it stood at $2.1 million in 2021, then increased by 27.44% to $2.7 million in 2022, then fell by 12.41% to $2.4 million in 2023, then dropped by 0.04% to $2.4 million in 2024, then plummeted by 51.79% to $1.1 million in 2025.
  • Per Business Quant, the three most recent readings for VHC's Research & Development are $1.1 million (Q3 2025), $1.2 million (Q2 2025), and $1.3 million (Q1 2025).